Scientists isolate Genes that made 1918 Flu
lethal
Newswise — By mixing and matching a
contemporary flu virus with the “Spanish
flu” — a virus that killed between 20 and 50
million people 90 years ago in history’s
most devastating outbreak of infectious
disease — researchers have identified a set
of three genes that helped underpin the
extraordinary virulence of the 1918 virus.
Writing today in the Proceedings of the
National Academy of Sciences, a team led by
University of Wisconsin-Madison virologists
Yoshihiro Kawaoka and Tokiko Watanabe
identifies genes that gave the 1918 virus
the capacity to reproduce in lung tissue, a
hallmark of the pathogen that claimed more
lives than all the battles of World War I
combined.
“Conventional flu viruses replicate mainly
in the upper respiratory tract: the mouth,
nose and throat. The 1918 virus replicates
in the upper respiratory tract, but also in
the lungs,” causing primary pneumonia among
its victims, says Kawaoka, an
internationally recognized expert on
influenza and a professor of pathobiological
sciences in the UW-Madison School of
Veterinary Medicine. “We wanted to know why
the 1918 flu caused severe pneumonia.”
Autopsies of 1918 flu victims often revealed
fluid-filled lungs severely damaged by
massive hemorrhaging. Scientists assumed
that the ability of the virus to take over
the lungs is associated with the pathogen’s
high level of virulence, but the genes that
conferred that ability were unknown.
Discovery of the complex and its role in
orchestrating infection in the lungs is
important because it could provide a way to
quickly identify the potential virulence
factors in new pandemic strains of
influenza, Kawaoka says.
The complex could
also become a target for a new class of
antiviral drugs, which is urgently needed as
vaccines are unlikely to be produced fast
enough at the outset of a pandemic to blunt
its spread.
To find the gene or genes that enabled the
virus to invade the lungs, Kawaoka and his
group blended genetic elements from the 1918
flu virus with those of a currently
circulating avian influenza virus and tested
the variants on ferrets, an animal that
mimics human flu infection.
For the most part, substituting single genes
from the 1918 virus onto the template of a
much more benign contemporary virus yielded
agents that could only replicate in the
upper respiratory tract.
One exception,
however, included a complex of three genes
that, acting in concert with another key
gene, allowed the virus to efficiently
colonize lung cells and make RNA polymerase,
a protein necessary for the virus to
reproduce.
“The RNA polymerase is used to make new
copies of the virus,” Kawaoka explains.
Without the protein, the virus is unable to
make new virus particles and spread
infection to nearby cells.
In the late 1990s, scientists were able to
recover genes from the 1918 virus by looking
in the preserved lung tissue of some of the
pandemic’s victims.
Using the relic genes, Kawaoka’s group was able to generate viruses
that carry different combinations of the
1918 virus and modern seasonal influenza
virus.
When tested, most of the hybrid viruses only
infected the nasal passages of ferrets and
didn’t cause pneumonia.
But one did infect
the lungs, and it carried the RNA polymerase
genes from the 1918 virus that allowed the
virus to make the key step of synthesizing
its proteins.
In 2004, Kawaoka and his team identified
another key gene from the 1918 virus that
enhanced the pathogen’s virulence in mice.
That gene makes hemagglutinin, a protein
found on the surface of the virus and that
confers on viral particles the ability to
attach to host cells.
“Here, I think we are talking about another
mechanism,” Kawaoka says. The RNA polymerase
is used to make copies of the virus once it
has entered a host cell.
The role of hemagglutinin is to help the virus gain
access to cells.
In addition to the study’s lead authors,
Watanabe and Kawaoka, co-authors of the new
PNAS paper are Shinji Watanabe, Jin Hyun Kim
and Masato Hatta, also of UW-Madison; and
Kyoko Shinya of Kobe University. The work
was funded by the Japanese Ministry of
Education, Culture, Sports, Science and
Technology and by grants-in-aid from the
Ministry of Health, Labor and Welfare of
Japan.